Innovator IBD ETF Leaders ETF

Frequently Asked Questions About LDRS

What does LDRS invest in?

The investment seeks to track, before fees and expenses, the performance of the IBD® ETF Leaders Index. The fund normally invests at least 80% of its net assets (including investment borrowings) in the exchange-traded investment companies that comprise the index. It generally invests in all of the securities comprising the index in proportion to the weightings of the securities in the index. The index is a rules-based index owned and developed by Investor's Business Daily® designed to attempt to outperform the broader equity and fixed income markets. The fund is non-diversified.

What is the expense ratio of LDRS?

Innovator IBD ETF Leaders ETF (LDRS) charges an expense ratio of 0.00%. This is the annual fee deducted from fund assets to cover management and operations.

How big is LDRS?

Innovator IBD ETF Leaders ETF (LDRS) manages $8.2M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is LDRS actively managed or an index fund?

LDRS is a passive index fund — it tracks a published benchmark by holding the constituents in their published weights. Index funds typically charge low expense ratios (LDRS's is 0.00%) because there's no security selection cost.

When was LDRS launched?

Innovator IBD ETF Leaders ETF (LDRS) launched in December 2017 and is managed by Innovator.

How has LDRS performed?

LDRS's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.